Engineering Blood Cells | The Enterprise Sessions with Profs Ash Toye and Jan Frayne

About this episode

This episode features a discussion on the journey from academic research to founding a biotechnology company focused on lab-grown blood cells.

In this episode of Enterprise Sessions from the University of Bristol, Professor Michele Barbour sits down with Professor Ash Toye and Professor Jan Frayne, two leading biochemists whose long‑standing research partnership has evolved into one of the UK’s most exciting biotechnology spin‑outs: Scarlet Therapeutics. Together, Ash and Jan share the remarkable journey from academic collaboration to scientific breakthrough — and ultimately to founding a company built on the promise of lab‑grown an...

People in this episode

Host: Professor Michele Barbour

Guests: Professor Ash Toye, Professor Jan Frayne

Topics covered

• biotechnology
• academic collaboration
• scientific breakthrough
• lab-grown blood cells
• entrepreneurship

Keywords

• biochemistry
• Scarlet Therapeutics
• lab-grown cells
• biotechnology
• academic research

Mentioned in this episode

Organizations: Scarlet Therapeutics, University of Bristol

More episodes of ResearchPod

• Listeria, Listeriosis, and Public Health · May 12, 2026 · 12 min
• Shrinkflation: Does size really matter? · May 8, 2026 · 9 min
• Hormone replacement therapy and how to take it safely · May 6, 2026 · 9 min
• Lasers, Ivory & Unexpected Entrepreneurship | The Enterprise Sessions with Dr Rebecca Shepherd · April 29, 2026 · 49 min
• Aesthetics and food shopping: why consumers reject unattractive produce · April 28, 2026 · 11 min
• Modelling the World’s Floods & Building Fathom | The Enterprise Sessions with Professor Paul Bates · April 15, 2026 · 44 min